Business / Finance

RSS

Advocate Health Care renews performance improvement relationship with MedAssets

MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.

3 Jan 2014

City of Hope to offer radiation oncology services to patients in the Arcadia area

City of Hope and Methodist Hospital of Southern California have reached an agreement in which City of Hope will acquire the hospital's radiation oncology service in Arcadia. The acquisition will expand access to City of Hope's renowned expertise in radiation therapy and will provide additional convenience for patients seeking specialized cancer services.

2 Jan 2014

Healthcare Trust of America closes $156 million of acquisitions in fourth quarter 2013

Healthcare Trust of America, Inc. announced today that it had closed approximately $156 million of acquisitions in the fourth quarter of 2013. The fourth quarter acquisitions were highlighted by the agreement to acquire an eight medical office building portfolio from a regional developer in Florida for $141 million, $127 million of which closed in December (the "Florida Portfolio").

2 Jan 2014

Neogen acquires the stock of Chem-Tech

Neogen Corporation announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.

2 Jan 2014

AtriCure completes previously announced acquisition of Endoscopic Technologies

AtriCure, Inc., a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a Estech. Estech develops and markets a portfolio of innovative surgical ablation devices that enable physicians to perform a variety of traditional and minimally invasive procedures using Estech's proprietary temperature controlled RF energy.

2 Jan 2014

ProAssurance acquires Eastern Insurance Holdings

ProAssurance Corporation announced today that its acquisition of Eastern Insurance Holdings, Inc. was completed effective January 1, 2014. Eastern's shareholders overwhelmingly approved the transaction at a special meeting on December 27, 2013.

2 Jan 2014

China's Health Department of the People's Liberation Army orders clinical solutions from Elekta

To help manage the growing incidence of cancer, China's Health Department of the People's Liberation Army has ordered a comprehensive range of clinical solutions from Elekta. Fourteen hospitals around the country will receive in total 15 linear accelerators (linacs).

From Elekta 2 Jan 2014

MEDNAX acquires Summit Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of Summit Anesthesia Associates, P.A., a physician group practice primarily based in Summit, New Jersey. The practice will become part of MEDNAX's American Anesthesiology division and is the second New Jersey-based anesthesiology practice to join this division.

2 Jan 2014

Fiat to purchase entire equity interest of UAW Retiree Medical Benefits Trust in Chrysler Group

The UAW Retiree Medical Benefits Trust (Trust) is pleased to confirm that an agreement has been reached between the Trust's Independent Fiduciary and Fiat North America LLC regarding a purchase of the Trust's entire equity interest in Chrysler Group LLC.

2 Jan 2014

BioCryst receives $2.5M to advance development of BCX4430 for Marburg virus disease treatment

BioCryst Pharmaceuticals, Inc. today announced that the National Institute of Allergy and Infectious Diseases has exercised an option to conduct the investigational new drug enabling program and to submit an IND.

30 Dec 2013

Shire extends expiration of tender offer for all outstanding shares of ViroPharma

Shire plc,announces that it has extended the expiration of its previously announced tender offer by a wholly owned subsidiary of Shire for all of the outstanding common shares of ViroPharma (NASDAQ: VPHM) until midnight, New York City time, on Thursday, January 9, 2014 (one minute after 11:59 p.m., New York City time, on January 9, 2014).

27 Dec 2013

CEL-SCI closes public offering of common stock, exercises over-allotment option to purchase additional shares

CEL-SCI Corporation, a late-stage oncology company, today announced that it has closed an underwritten public offering of units consisting of an aggregate of 5,238,095 shares of common stock and warrants to purchase an aggregate of 5,238,095 shares of common stock. The

27 Dec 2013

Oramed Pharmaceuticals to purchase $15,800,000 shares in registered direct offering

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, today announced that it has entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price of $10.00 per share in a registered direct offering.

26 Dec 2013

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, announced today that its investor group and employee shareholders have reached a definitive agreement to sell the Commercial Business to Madison Dearborn Partners in a transaction valued at approximately $1.6 billion.

26 Dec 2013

Taro declares preliminary results of modified tender to repurchase $200M shares

Taro Pharmaceutical Industries Ltd.("Taro" or the "Company") today announced the preliminary results of its modified "Dutch auction" tender offer to repurchase up to $200 million in value of its ordinary shares, which expired at 12:00 midnight, New York City time, on Monday, December 23, 2013.

26 Dec 2013

Madison Dearborn Partners signs definitive agreement to acquire Ikaria

Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.

25 Dec 2013

Bioanalytical Systems reports net income of $252,000 for fourth quarter 2013

Bioanalytical Systems, Inc. today announced financial results for the fourth quarter and fiscal 2013, highlighted by net income of $252,000, or $0.03 per diluted share, for the fourth quarter and $773,000, or $0.09 per diluted share, for the year. This compares to net losses of $2,696,000, or $0.36 per share and $6,317,000, or $0.88 per share, for the fourth quarter and fiscal 2012.

24 Dec 2013

Concordia Healthcare acquires Pinnacle Biologics

Concordia Healthcare Corp., an integrated, specialty healthcare company focused on the acquisition of legacy pharmaceutical products and medical devices and the acquisition and/or development of orphan drugs, announced today that it has acquired Pinnacle Biologics, Inc., a U.S.-based biopharmaceutical company specializing in legacy pharmaceuticals which have the potential for development as orphan drugs to treat cancer indications in addition to those for which they have previously been approved.

24 Dec 2013

Dynasil announces sale of Navigator Gamma Medical Probe product line to Dilon Technologies

Dynasil Corporation of America, a developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today announced the December 23, 2013 sale of the assets of its Navigator Gamma Medical Probe product line to Dilon Technologies, Inc. of Newport News, Virginia.

24 Dec 2013

Planmeca to co-develop CAD/CAM products with E4D Technologies

Planmeca, the world's largest privately owned dental imaging company and equipment manufacturer, announced today that it has made a non-controlling, strategic investment in E4D Technologies, LLC, developer of the E4D CAD/CAM Restorative System. This strategic investment reinforces Planmeca's on-going commitment to help dental providers improve patient care by offering a comprehensive portfolio of integrated digital dental solutions for dentists and dental laboratories.

24 Dec 2013

Business / Finance

Advocate Health Care renews performance improvement relationship with MedAssets

City of Hope to offer radiation oncology services to patients in the Arcadia area

Healthcare Trust of America closes $156 million of acquisitions in fourth quarter 2013

Neogen acquires the stock of Chem-Tech

AtriCure completes previously announced acquisition of Endoscopic Technologies

ProAssurance acquires Eastern Insurance Holdings

China's Health Department of the People's Liberation Army orders clinical solutions from Elekta

MEDNAX acquires Summit Anesthesia Associates

Fiat to purchase entire equity interest of UAW Retiree Medical Benefits Trust in Chrysler Group

BioCryst receives $2.5M to advance development of BCX4430 for Marburg virus disease treatment

Shire extends expiration of tender offer for all outstanding shares of ViroPharma

CEL-SCI closes public offering of common stock, exercises over-allotment option to purchase additional shares

Oramed Pharmaceuticals to purchase $15,800,000 shares in registered direct offering

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Taro declares preliminary results of modified tender to repurchase $200M shares

Madison Dearborn Partners signs definitive agreement to acquire Ikaria

Bioanalytical Systems reports net income of $252,000 for fourth quarter 2013

Concordia Healthcare acquires Pinnacle Biologics

Dynasil announces sale of Navigator Gamma Medical Probe product line to Dilon Technologies

Planmeca to co-develop CAD/CAM products with E4D Technologies

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News